Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Novochizol SA logo — First-in-class Polysaccharide Nanotechnology

Novochizol SA

First-in-class Polysaccharide Nanotechnology

Founded 2021 Switzerland Monthey, Switzerland 4 employees

General Information

Company Name Novochizol SA
Founded Year 2021
Location Switzerland Monthey, Switzerland +1
Employees 4
Social

Get notified when Novochizol SA moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Novochizol SA

Novochizol™ technology quantitatively transforms single linear chitosan molecules into uniformly sized nanoparticles that can be used alone, as emulsifiers or carriers of active ingredients. Novochizol™ overcomes the limitations of chitosan, enhances its existing beneficial properties and displays new characteristics: - Formulation of all API classes: small molecules, peptides, nucleic acids, proteins, viruses and cells. - Low viscosity solutions/suspensions under all conditions - Administration-targeted drug release, without systemic distribution - Customizable sustained release properties - Slow biodegradation and physical robustness - Intracellular delivery of active ingredients, including proteins.

No funding data available for Novochizol SA yet.

Get notified when Novochizol SA raises funding

Novochizol SA Alternatives & Competitors

Novochizol SA vs
Medoderm GmbH
Medoderm GmbH Germany

Focussing on the manufacturing of innovative, highly effective wound and skin care products. Biotech...

3 employees
Health Care
Novochizol SA vs
Inseco
Inseco South Africa

Redefining protein creation & facilitating the transition towards a circular economy

Seed
14 employees
Agriculture, Biotechnology
Novochizol SA vs
Allinky Biopharma
Allinky Biopharma

Among the therapeutic areas of partnering interest, for the top pharmaceutical companies, oncology,...

3 employees
Biotechnology, Health Care

FAQ About Novochizol SA

First-in-class Polysaccharide Nanotechnology
Novochizol SA was founded in 2021.
Novochizol SA is headquartered in Monthey, Switzerland.
Novochizol SA has approximately 4 employees.
Top alternatives and competitors to Novochizol SA include Medoderm GmbH, Inseco, Allinky Biopharma, Acthera Therapeutics Ltd., LKT Laboratories, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Novochizol SA and Medoderm GmbH are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Novochizol SA and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy